Objective-To identify valvar heart disease in patients with chronic uraemia by conventional and colour coded Dop- 
Setting-Centre for haemodialysis in a referral hospital in Switzerland.
Patients-62 patients on chronic haemodialysis.
Main outcome measures-Frequency of structural and functional valve abnormalities and their relation to clinical findings.
Results-Structural changes were seen in 40 (64%) of 62 patients after 50 months (range 3-178 months) on haemodialysis.
The mitral annulus and aortic cusps were thickened in 25 (40%) and in 34 (55%) patients respectively. Aortic stenosis was present in eight (mean (SD) age 60 5 (8 5) years), with a maximal instantaneous pressure gradient of 41 (14) The interval since diagnosis of hypertension was similar in patients with and without structural abnormalities of the valves (10 9 (6 4) (20) 144 (19) 141 (21) 140 (22) 141 (20) Diastolicbloodpressure(mmnHg) 83 (11) 83 (9) 83 (12) 82 (11) 83 (12) Haemoglobin(g/l) 101 (1-7) 99 (1) (2) (3) (4) (5) (6) (7) (8) 102 (1) (2) (3) (4) (5) (6) This accords with a report linking aortic sclerosis with renal osteodystrophy.' Nevertheless, the ranges for alkaline phosphatase and parathyroid hormone were too wide to predict the risk of aortic stenosis developing in individual patients with high serum concentrations. In addition, we used a C-terminal parathyroid hormone assay, which because it also measures the inactive metabolites of parathyroid hormone, is not very specific.
An increased calcium-phosphate product caused by secondary hyperparathyroidism and the failure to control hyperphosphataemia have been associated with premature calcification of the aortic valve and mitral annulus."5 21 25 Maher et al found that the calcium-phosphate product was greater in patients with aortic calcification than in those without.2' This finding contrasts with our patients who did not show a significant increase in the calcium-phosphate product despite the increase in parathyroid hormone concentrations. This discrepancy is not easy to explain but might be related to good control of phosphataemia in our patients, at least during the last 12 months on dialysis. Furthermore, others have reported similar findings to ours.4
The sensitivity of the clinical diagnosis of heart valve disease in the current study was low: 60% for aortic stenosis and 40% for mitral regurgitation. This accords with other studies."3'2 Aortic stenosis was clinically diagnosed in only two out of five patients in a comparable study by Maher.2" In a study by Labovitz 17 
